Regulation of complement activation by C-reactive protein

Immunopharmacology

Volumn 42, Issue 1-3, 1999, Pages 23-30

  Mold, Carolyn ^a   Gewurz, Henry ^c   Du Clos, Terry W ^b,d  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NEW MEXICO   (United States)

^c RUSH MEDICAL COLLEGE   (United States)

^d VA Medical Center   (United States)

Author keywords

Acute phase reactants; Complement; Inflammation; Inflammatory mediators

Indexed keywords

C REACTIVE PROTEIN; COMPLEMENT COMPONENT C1; COMPLEMENT COMPONENT C2; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; COMPLEMENT FACTOR H; COMPLEMENT MEMBRANE ATTACK COMPLEX; EDETIC ACID; PHOSPHORYLCHOLINE;

COMPLEMENT ACTIVATION; CONFERENCE PAPER; ENZYME LINKED IMMUNOSORBENT ASSAY; LIGAND BINDING; NEISSERIA GONORRHOEAE; PHAGOCYTE; PRIORITY JOURNAL; STREPTOCOCCUS PYOGENES;

AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; C-REACTIVE PROTEIN; COMPLEMENT ACTIVATION; HUMANS; MOLECULAR SEQUENCE DATA;

EID: 0032992715     PISSN: 01623109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-3109(99)00007-7     Document Type: Conference Paper

References (47)

1. Agrawal A., Volanakis J.E. Probing the C1q-binding site on human C-reactive protein by site-directed mutagenesis. J. Immunol. 152:1994;5404-5410.
2. Ahmed N., Thorley R., Zia D., Samols D., Webster R.O. Transgenic mice expressing rabbit C-reactive protein exhibit diminished chemotactic factor-induced alveolitis. Am. J. Respir. Crit. Care Med. 153:1996;1141-1147.
3. Berman S., Gewurz H., Mold C. Binding of C-reactive protein to nucleated cells leads to complement activation without cytolysis. J. Immunol. 136:1986;1354-1359.
4. Blackmore T.K., Sadlon T.A., Ward H.M., Lublin D.M., Gordon D.L. Identification of a heparin binding domain in the seventh short consensus repeat of complement factor H. J. Immunol. 157:1996;5422-5427.
5. Carreno M.P., Labarre D., Maillet F., Jozefowicz M., Kazatchkine M.D. Regulation of the human alternative complement pathway: formation of a ternary complex between factor H, surface-bound C3b and chemical groups on nonactivating surfaces. Eur. J. Immunol. 19:1989;2145-2150.
6. China B., Sory M.-P., N'guyen B.T., De Bruyere M., Cornelis G.R. Role of the YadA protein in prevention and opsonization of Yersinia enterocolitica by C3b molecules. Infect. Immun. 61:1993;3129-3136.
7. Crowell R.E., Du Clos T.W., Montoya G., Heaphy E., Mold C. C-reactive protein receptors on the human monocytic cell line U-937. Evidence for additional binding to FcγRI. J. Immunol. 147:1991;3445-3451.
8. Du Clos T.W. C-reactive protein reacts with the U1 small nuclear ribonucleoprotein. J. Immunol. 143:1989;2553-2559.
9. Du Clos T.W. The interaction of C-reactive protein and serum amyloid P component with nuclear antigens. Mol. Biol. Rep. 23:1996;253-260.
10. Du Clos T.W., Mold C., Stump R.F. Identification of a polypeptide sequence that mediates nuclear localization of the acute phase protein C-reactive protein. J. Immunol. 145:1990;3869-3875.
11. Du Clos T.W., Zlock L., Marnell L.L. Definition of a C-reactive protein binding determinant on histones. J. Biol. Chem. 266:1991;2167-2171.
12. Du Clos T.W., Zlock L.T., Hicks P.S., Mold C. Decreased autoantibody levels and enhanced survival of (NZB×NZW) F1 mice treated with C-reactive protein. Clin. Immunol. Immunopathol. 70:1994;22-27.
13. Edwards M.S., Kasper D.L., Jennings H.J., Nicholson-Weller A. Capsular sialic acid prevents activation of the alternative complement pathway of type III, group B streptococci. J. Immunol. 128:1982;1278-1283.
14. Fischetti V.A., Horstmann R.D., Pancholi V. Location of the complement factor H binding site on streptococcal M6 protein. Infect. Immun. 63:1995;149-153.
15. Gewurz H., Zhang X.H., Lint T.F. Structure and function of the pentraxins. Curr. Opin. Immunol. 7:1995;54-64.
16. Jiang H., Siegel J.N., Gewurz H. Binding and complement activation by C-reactive protein via the collagen-like region of C1q and inhibition of these reactions by monoclonal antibodies to C-reactive protein and C1q. J. Immunol. 146:1991;2324-2330.
17. Kaplan M.H., Volanakis J.E. Interactions of C-reactive protein with the complement system: I. Consumption of human complement associated with the reaction of C-reactive protein with pneumococcal polysaccharide and with the choline phosphatides, lecithin and sphingomyelin. J. Immunol. 112:1974;2135-2147.
18. Kilpatrick J.M., Volanakis J.E. Opsonic properties of C-reactive protein. Stimulation by phorbol myristate acetate enables human neutrophils to phagocytize C-reactive protein-coated cells. J. Immunol. 134:1985;3364-3370.
19. Lambris J.D., Avila D., Becherer J.D., Müller-Eberhard H.J. A discontinuous factor H binding site in the third component of complement as delineated by synthetic peptides. J. Biol. Chem. 263:1988;12147-12150.
20. Lambris J.D., Lao Z., Oglesby T.J., Atkinson J.P., Hack E., Becherer J.D. Dissection of CR1, factor H, MCP, and factor B binding and functional sites in third complement component. J. Immunol. 156:1996;4821-4832.
21. Li Y.-P., Mold C., Du Clos T.W. Sublytic complement attack exposes C-reactive protein binding sites on cell membranes. J. Immunol. 152:1994;2995-3005.
22. Marnell L.L., Mold C., Volzer M.A., Burlingame R.W., Du Clos T.W. C-reactive protein binds to FcγRI in transfected COS cells. J. Immunol. 155:1995;2185-2193.
23. Meri S., Pangburn M.K. Discrimination between activators and nonactivators of the alternative pathway of complement: regulation via a sialic acid/polyanions binding site on factor H. Proc. Natl. Acad. Sci. U.S.A. 87:1990;3982-3986.
24. Mold C., Gewurz H. Inhibitory effect of C-reactive protein on alternative C pathway activation by liposomes and Streptococcus pneumoniae. J. Immunol. 127:1981;2089-2092.
25. Mold C., Nakayama S., Holzer T.J., Gewurz H., Du Clos T.W. C-reactive protein is protective against Streptococcus pneumoniae infection in mice. J. Exp. Med. 154:1981;1703-1708.
26. Mold C., Kingzette M., Gewurz H. C-reactive protein inhibits pneumococcal activation of the alternative pathway by increasing the interaction between factor H and C3b. J. Immunol. 133:1984;882-885.
27. Mold C., Gurulé C., Otero D., Du Clos T.W. Complement-dependent binding of C-reactive protein complexes to human erythrocyte CR1. Clin. Immunol. Immunopathol. 81:1996;153-160.
28. Pangburn M.K., Atkinson M.A.L., Meri S. Localization of the heparin-binding site on complement factor H. J. Biol. Chem. 266:1991;16847-16853.
29. Ram S., McQuillen D.P., Gulati S., Elkins C., Pangburn M.K., Rice P.A. Binding of complement factor H to loop 5 of porin protein 1A: a molecular mechanism of serum resistance of nonsialylated Neisseria gonorrhoeae. J. Exp. Med. 188:1998;671-680.
30. Ram S., Sharma A.K., Simpson S.D., Gulati S., McQuillen D.P., Pangburn M.K., Rice P.A. A novel sialic acid binding site on factor H mediates serum resistance of sialylated Neisseria gonorrhoeae. J. Exp. Med. 187:1998;743-752.
31. Reid K.B.M., Colomb M.G., Loos M. Complement component C1 and the collectins: parallels between routes of acquired and innate immunity. Immunol. Today. 19:1998;56-59.
32. Richards R.L., Gewurz H., Osmand A.P., Alving C.R. Interactions of C-reactive protein and complement with liposomes. Proc. Natl. Acad. Sci. U.S.A. 74:1977;5672-5676.
33. Romero I.R., Morris C., Rodriguez M., Du Clos T.W., Mold C. Inflammatory potential of C-reactive protein complexes compared to immune complexes. Clin. Immunol. Immunopathol. 87:1998;155-162.
34. Siegel J., Rent R., Gewurz H. Interactions of C-reactive protein with the complement system: I. Protamine-induced consumption of complement in acute phase sera. J. Exp. Med. 140:1974;631-647.
35. Steel D.M., Whitehead A.S. The major acute phase reactants: C-reactive protein, serum amyloid P component, and serum amyloid A protein. Immunol. Today. 15:1994;81-88.
36. Suankratay C., Mold C., Zhang Y., Potempa L.A., Lint T.F., Gewurz H. Complement regulation in innate immunity: inhibition of mannan-binding lectin-initiated complement cytolysis by C-reactive protein. Clin. Exp. Immunol. 113:1998;353-359.
37. Suankratay C., Zhang X.-H., Zhang Y., Lint T.F., Gewurz H. Requirement for the alternative pathway as well as C4 and C2 in complement-dependent hemolysis via the lectin pathway. J. Immunol. 160:1998;3006-3013.
38. Szalai A.J., Briles D.E., Volanakis J.E. Human C-reactive protein is protective against fatal Streptococcus pneumoniae infection in transgenic mice. J. Immunol. 155:1995;2557-2563.
39. Szalai A.J., Agrawal A., Greenhough T.J., Volanakis J.E. C-reactive protein. Structural biology, gene expression and host defense function. Immunol. Res. 16:1997;127-136.
40. Tebo J., Mortensen R.F. Characterization and isolation of a C-reactive protein receptor from the human monocytic cell line U-937. J. Immunol. 144:1990;231-238.
41. Tilg H., Dinarello C.A., Mier J.W. IL-6 and APPs: anti-inflammatory and immunosuppressive mediators. Immunol. Today. 18:1997;428-432.
42. Tuomanen E.I. The biology of pneumococcal infection. Pediatr. Res. 42:1997;253-258.
43. Vik D.P., Munoz-Canoves P., Chaplin D.D., Tack B.F. Factor H. Curr. Topics Microbiol. Immunol. 153:1990;147-162.
44. Volanakis J.E., Kaplan M.H. Specificity of C-reactive protein for choline phosphate residues of pneumococcal C-polysaccharide. Proc. Soc. Exp. Biol. Med. 136:1971;612.
45. Volanakis J.E., Wirtz K.W.A. Interaction of C-reactive protein with artificial phosphatidylcholine bilayers. Nature. 281:1979;155-157.
46. Weiser J.N., Pan N., McGowan K.L., Musher D., Martin A., Richards J. Phosphorylcholine on the lipopolysaccharide of Haemophilus influenzae contributes to persistence in the respiratory tract and sensitivity to serum killing mediated by C-reactive protein. J. Exp. Med. 187:1998;631-640.
47. Xia D., Samols D. Transgenic mice expressing rabbit C-reactive protein (CRP) are resistant to endotoxemia. Proc. Natl. Acad. Sci. U.S.A. 94:1997;2575-2580.